HE TOP HARDENER FAST

Hazard statements (CLP)

H225, H304, H315, H317, H319, H332, H335, H336, H361d, H373, H412

Code

Statements

H225

Highly Flammable liquid and vapour

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

Classification of mixtures is carried out in accordance with the following principles: a) when data (tests) for the classification of mixtures are available, generally is carried out based on these data, b) in the absence of data (tests) for mixtures are generally used interpolation or extrapolation methods of assessing the risk, using the available data for mixtures similarly classified, and c) in the absence of tests and information which would allow to apply interpolation or extrapolation techniques, methods are used to classify risk assessment based on the data of the individual components in the mixture. Classification in accordance with Regulation (EU) No. 1272/2008~2021/849 (CLP): DANGER Flam. Liq. 2 H225|Acute Tox. (inh.) 4 H332|Skin Irrit. 2 H315|Eye Irrit. 2 H319|Skin Sens. 1 H317|Repr. 2 H361d|STOT SE (irrit.) 3 H335|STOT SE (narcosis) 3 H336|STOT RE 2 H373|Asp. Tox. 1 H304|Aquatic Chronic 3 H412 Danger class Cat.

Principle Routes of Exposure

Target organs Effects Physicochemical: Flam. Liq. 2:H225 c) Cat.2 - Human health: Acute Tox. (inh.) 4:H332 c) Cat.4 Inhalation - Harmful Skin Irrit. 2:H315 c) Cat.2 Skin Irritation Eye Irrit. 2:H319 c) Cat.2 Eyes Irritation Skin Sens. 1:H317 c) Cat.1 Skin Allergy Repr. 2:H361d c) Cat.2 - Reproductive Foetus STOT SE (irrit.) 3:H335 c) Cat.3 Inhalation system Irritation STOT SE (narcosis) 3:H336 c) Cat.3 Inhalation Respiratory tract Narcosis STOT RE 2:H373 c) Cat.2 Inhalation CNS Damage Asp. Tox. 1:H304 c) Cat.1 Ingestion+Aspiration Systemic Dead Lungs

Environmental hazards

Aquatic Chronic 3:H412 c) Cat.3 - Full text of hazard statements mentioned is indicated in section 16. Note: When in section 3 a range of percentages is used, the health and environmental hazards describe the effects of the highest concentration of each component, but below the maximum value.

2.2 Label elements

This product is labelled with the signal word DANGER in accordance with Regulation (EU) No. 1272/2008~2021/849 (CLP)

Hazard statements

H225 Highly flammable liquid and vapour. H361d Suspected of damage the unborn child. H373 May cause damage to organs through prolonged or repeated exposure if inhaled. H332 Harmful if inhaled. H304 May be fatal if swallowed and enters airways. H319 Causes serious eye irritation. H335 May cause respiratory irritation. H315 Causes skin irritation. H336 May cause drowsiness or dizziness. H317 May cause an allergic skin reaction. H412 Harmful to aquatic life with long lasting effects.

Precautionary statements

P102 Keep out of reach of children. P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P370+P378 In case of fire Use ... to extinguish. [indicate in the space the precise type of fire-fighting equipment]. (If water increases risk, add ''Never use water''). P280 Wear protective gloves, clothing and eye protection. In case of inadequate ventilation wear respiratory protection. P301+P310 IF SWALLOWED: Immediately call a POISON CENTER or doctor. P331 Do NOT induce vomiting. P403+P235 Store in a well-ventilated place. Keep cool.

Hazardous Ingredients

HDI oligomers, isocyanurate Isobutyl acetate Reaction mass of ethylbenzene and xilene Other sensitizing components: Reaction mass of bis(1,2,2,6,6-pentamethyl-4-piperidil) sebacate and methyl 1,2,2,6,6-pentamethyl-4-piperydyl sebacate,Pentaerythritol tetrakis(3-mercaptopropionate),Ethylene bis(3-mercaptopropionate)

Other physicochemical hazards

Vapours may form with air a mixture potentially flammable or explosive.

Potential health effects

People with hypersensitive respiratory tract (by instance, asthma or chronical bronchitis) should not handle this product.

Environmental effects

Does not contain substances that fulfil the PBT/vPvB criteria. Endocrine disrupting properties: This product contains substances with endocrine disrupting properties under evaluation in a concentration equal to or greater than 0.1% by weight: 2,6-di-tert-butyl-p-cresol.